Introducing MDoutlook™ – a global oncology intelligence platform


In partnership with Dr Chandra Belani and Dr Giorgio Scagliotti, The Arcas Group is introducing MDoutlook™: a robust and dynamic oncology intelligence platform that will deliver exclusive clinician reported treatment data combined with unique insight and perspective provided by global oncology ThoughtLeaders.

A brief introduction to MDoutlook™:

  • Developed with and guided by prominent global ThoughtLeaders:

    • Chandra Belani, MD, chairs MDoutlook™ United States

    • Giorgio Scagliotti, MD, PhD, chairs MDoutlook™ Europe

  • MDoutlook™ has been developed with a singular focus: improved understanding of the oncology marketplace by delivering comprehensive data, unique intelligence, and exclusive access to ThoughtLeader analysis.

  • Data collection is driven by standing global cancer clinician panels in both the U.S. & Europe who record and report on their daily treatment activity, prescription selections and decision rationale.

  • Information and intelligence is augmented by clinician data sourcing that delivers >10% of global cancer clinicians.

  • ThoughtLeader advisers have contractually committed with MDoutlook™ to review the targeted cancer landscape, and all clinician-provided treatment data – in order to deliver their exclusive market and product specific intelligence via monthly reports and dedicated live forums.

For more information, please contact us here.


The Future Is Now: Consultants Spotlight

Interview by Marylyn Donahue of Pharmaceutical Executive about the challenges facing the pharmaceutical and biotech industry, and what areas of focus would help to overcome these challenges. You can read our contributions by clicking here. For a copy of the entire article, please use this link.